Troy Rohn

Dr. Troy Rohn is an advocate for innovation in the field of biological sciences, with a particular focus on neurodegenerative diseases and mental health disorders. As a distinguished faculty member at Boise State University since 2000, Dr. Rohn has dedicated his career to advancing our understanding of Alzheimer's disease and anxiety. He holds a Bachelor of Science degree in Physiology from the University of California, Davis, and a PhD in Pharmacology from the University of Washington, Seattle, which have provided him with a robust foundation for his research endeavors. Dr. Rohn's research is primarily centered on the role of the ApoE4 gene in Alzheimer's disease, a critical area of study given the gene's strong association with the risk of developing this debilitating condition. His work aims to unravel the complex mechanisms by which ApoE4 contributes to the pathogenesis of Alzheimer's, with the ultimate goal of identifying potential therapeutic targets that could lead to more effective treatments. In addition to his work on Alzheimer's disease, Dr. Rohn is actively engaged in exploring novel treatments for anxiety. He is currently involved in groundbreaking clinical trials that utilize CRISPR/Cas9 technology to develop a new drug aimed at treating anxiety disorders. This innovative approach has the potential to revolutionize the way anxiety is treated, offering hope to millions of individuals who suffer from this condition. Throughout his career, Dr. Rohn has been committed to fostering a collaborative research environment, encouraging interdisciplinary partnerships that enhance the scope and impact of his work. His dedication to mentoring the next generation of scientists is evident in his involvement with student research projects and his role in guiding young researchers as they embark on their scientific careers. Dr. Rohn's contributions to the field of biological sciences have been recognized through numerous publications in prestigious journals, as well as presentations at national and international conferences. His work continues to inspire both his colleagues and students, as he remains at the forefront of research aimed at improving human health and well-being.